Epicrispr Biotechnologies vs Immitra Bio
Epicrispr Biotechnologies vs Immitra Bio, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Immitra Bio on 48/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 48/100
- agent readiness: 39/100 against 29/100
- domain rating: 40/100 against 8/100
- funding raised: $90.0M against $2.6M
- LinkedIn following: 7,025 against 2,336
Immitra Bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Epicrispr Biotechnologies | Immitra Bio |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Scalable, one-time curative in-vivo gene editing therapies. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Gene Therapy, Genetics, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2020 | 2024 |
| Headquarters | South San Francisco, United States | Zürich, Switzerland |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Immitra Bio |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | $2.6M |
| Latest round | Series C | Pre-Seed |
| LinkedIn followers | 7,025 | 2,336 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Immitra Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 48/100 |
| Traction | 57/100 | 32/100 |
| Team | 40/100 | 70/100 |
| Search visibility | 20/100 | 33/100 |
| Quality | 78/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (29/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 8/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Immitra Bio |
|---|---|---|
| CDN | Cloudflare | Fastly |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Bootstrap |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs Immitra Bio: common questions
Which is better, Epicrispr Biotechnologies or Immitra Bio?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Immitra Bio compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 48/100), agent readiness (39/100 against 29/100), domain rating (40/100 against 8/100), funding raised ($90.0M against $2.6M), LinkedIn following (7,025 against 2,336).
Read the full Epicrispr Biotechnologies review and pricing or the Immitra Bio review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.